LU81253A1 - Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant - Google Patents

Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant

Info

Publication number
LU81253A1
LU81253A1 LU81253A LU81253A LU81253A1 LU 81253 A1 LU81253 A1 LU 81253A1 LU 81253 A LU81253 A LU 81253A LU 81253 A LU81253 A LU 81253A LU 81253 A1 LU81253 A1 LU 81253A1
Authority
LU
Luxembourg
Prior art keywords
alkylglycerols
immuno
derivatives
products containing
medicinal products
Prior art date
Application number
LU81253A
Other languages
English (en)
Inventor
A Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU81253A1 publication Critical patent/LU81253A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU81253A 1978-05-15 1979-05-14 Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant LU81253A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/906,260 US4173641A (en) 1978-05-15 1978-05-15 Di-O-n-alkyl glycerol derivatives as immune stimulants

Publications (1)

Publication Number Publication Date
LU81253A1 true LU81253A1 (fr) 1979-12-07

Family

ID=25422164

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81253A LU81253A1 (fr) 1978-05-15 1979-05-14 Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant

Country Status (38)

Country Link
US (1) US4173641A (fr)
JP (2) JPS5924974B2 (fr)
AR (1) AR221724A1 (fr)
AT (1) AT372678B (fr)
AU (1) AU513771B2 (fr)
BE (1) BE876229A (fr)
CA (1) CA1105935A (fr)
CH (1) CH639939A5 (fr)
DD (1) DD144540A5 (fr)
DE (1) DE2919514C2 (fr)
DK (1) DK149946C (fr)
EG (1) EG15252A (fr)
ES (1) ES480565A1 (fr)
FI (1) FI69450C (fr)
FR (1) FR2426039A1 (fr)
GB (1) GB2021580B (fr)
GR (1) GR72419B (fr)
GT (1) GT197957869A (fr)
HK (1) HK13584A (fr)
HU (1) HU180283B (fr)
IE (1) IE48229B1 (fr)
IL (1) IL57268A (fr)
IN (1) IN150574B (fr)
IT (1) IT1115217B (fr)
KE (1) KE3354A (fr)
LU (1) LU81253A1 (fr)
MY (1) MY8500096A (fr)
NL (1) NL175524C (fr)
NO (1) NO151285C (fr)
NZ (1) NZ190444A (fr)
PH (1) PH15256A (fr)
PL (1) PL123910B1 (fr)
PT (1) PT69607A (fr)
SE (1) SE429966B (fr)
SG (1) SG65483G (fr)
SU (1) SU1122220A3 (fr)
YU (1) YU41156B (fr)
ZA (1) ZA792306B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
US4310550A (en) * 1979-10-26 1982-01-12 Pfizer Inc. Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
US4395394A (en) * 1979-10-26 1983-07-26 Pfizer Inc. Use of lipid amines formulated with fat or lipid emulsions as vaccine adjuvants
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
US4880626A (en) * 1985-01-18 1989-11-14 Mcmichael John Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome
JPS62156230A (ja) * 1985-12-27 1987-07-11 Nippon Steel Corp 帯状物の蛇行修正方法
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
WO2005077963A1 (fr) * 2004-01-16 2005-08-25 Institut Superieur Agricole De Beauvais DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes.
SG10201407996PA (en) 2009-12-23 2015-01-29 Novartis Ag Lipids, lipid compositions, and methods of using them

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
US3432602A (en) * 1967-12-20 1969-03-11 Astra Ab Oral alkyl glycerol ether improvement in radiation,radiomimetic,or cytostatic tumor therapies
US3943173A (en) * 1972-11-22 1976-03-09 Smithkline Corporation 3-Alkylamino- alpha-aminomethyl-4-hydroxybenzyl alcohols
US4012528A (en) * 1974-06-03 1977-03-15 Smithkline Corporation α-AMINOALKYL-3-(1,2-DIHYDROXYETHYL)-4-HYDROXY-BENZYL ALCOHOLS HAVING β-ADRENERGIC STIMULANT ACTIVITY
US4069223A (en) * 1977-05-02 1978-01-17 G. D. Searle & Co. 4-Aminomethyl-1-(3,3,3-triarylpropyl)-4-arylpiperidine and derivatives thereof
US4166132A (en) * 1977-08-18 1979-08-28 Pfizer Inc. Antiviral amine derivatives of glycerol and propanediols

Also Published As

Publication number Publication date
AU4701679A (en) 1979-11-22
DK149946B (da) 1986-11-03
SE7904216L (sv) 1979-11-16
DK149946C (da) 1987-06-15
PH15256A (en) 1982-11-02
CA1105935A (fr) 1981-07-28
NO151285C (no) 1985-03-13
NO791604L (no) 1979-11-16
US4173641A (en) 1979-11-06
NZ190444A (en) 1981-05-29
MY8500096A (en) 1985-12-31
IE48229B1 (en) 1984-11-14
AR221724A1 (es) 1981-03-13
PL215573A1 (fr) 1980-07-01
FI69450B (fi) 1985-10-31
PL123910B1 (en) 1982-12-31
FR2426039B1 (fr) 1983-12-16
ATA356179A (de) 1983-03-15
DE2919514A1 (de) 1979-11-22
HK13584A (en) 1984-02-24
AU513771B2 (en) 1980-12-18
YU41156B (en) 1986-12-31
GR72419B (fr) 1983-11-03
HU180283B (en) 1983-02-28
DE2919514C2 (de) 1982-06-03
SG65483G (en) 1984-07-27
YU109479A (en) 1983-02-28
BE876229A (fr) 1979-11-14
ES480565A1 (es) 1980-08-16
FR2426039A1 (fr) 1979-12-14
FI69450C (fi) 1986-02-10
IT7922664A0 (it) 1979-05-14
KE3354A (en) 1983-12-16
EG15252A (en) 1986-09-30
JPS58131947A (ja) 1983-08-06
ZA792306B (en) 1980-05-28
PT69607A (en) 1979-06-01
JPS55378A (en) 1980-01-05
IE790938L (en) 1979-11-15
JPS6139301B2 (fr) 1986-09-03
GB2021580B (en) 1982-09-08
NL175524C (nl) 1984-11-16
NL7903769A (nl) 1979-11-19
FI791531A (fi) 1979-11-16
NO151285B (no) 1984-12-03
IL57268A (en) 1982-05-31
GT197957869A (es) 1980-11-04
CH639939A5 (fr) 1983-12-15
GB2021580A (en) 1979-12-05
SE429966B (sv) 1983-10-10
DK102479A (da) 1979-11-16
AT372678B (de) 1983-11-10
JPS5924974B2 (ja) 1984-06-13
SU1122220A3 (ru) 1984-10-30
DD144540A5 (de) 1980-10-22
IT1115217B (it) 1986-02-03
IL57268A0 (en) 1979-09-30
IN150574B (fr) 1982-11-13

Similar Documents

Publication Publication Date Title
MC1241A1 (fr) Derives de l'imidazole et leur preparation et preparation de medicaments contenant ces substances
MC1119A1 (fr) Derives de l'isoquinoleine,leur preparation et medicaments contenant ces substances
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
FR2279406A1 (fr) Nouveaux derives de quinazoline et medicament les contenant
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
BE865870A (fr) Derives du benzimidazole et medicaments qui en contiennent
FR2341307A1 (fr) Pyrethrinoides a titre de medicaments et compositions pharmaceutiques les renfermant
BE804558A (fr) Nouveaux derives de 2-amino- ou 4-amino-quinazoline et medicaments les contenant
BE869372A (fr) Derives de la prostaglandine i2 et medicaments qui en contiennent
FR2312240A1 (fr) Derives du prostane et medicaments qui en contiennent
FR2336129A1 (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
LU81253A1 (fr) Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant
BE863621A (fr) Nouveaux derives semi-synthetiques de 4"-erythromycine a et medicament les contenant
FR2312253A1 (fr) Derives de la piperazine et medicament contenant ces substances
FR2322593A1 (fr) Nouveaux analogues de prostaglandines et medicament les contenant
BE863620A (fr) Nouveaux derives 4"-amines d'oleandomycine et medicaments les contenant
FR2342971A1 (fr) Derives de la purine et medicament contenant ces substances
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
FR2315923A1 (fr) Derives de l'isoxazole et medicament contenant ces substances
BE853155A (fr) Nouveaux derives de sucres amines et medicament les contenant
BE841652A (fr) Derives de cardenolides et medicaments les contenant
BE781299A (fr) Derives de la 1(2h)-phtalazinone et medicaments en contenant
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances